Provided by Tiger Trade Technology Pte. Ltd.

Goldman Sachs Future Health Care Equity ETF

37.67
+0.37421.00%
Post-market: 37.44-0.2342-0.62%16:10 EDT
Volume:724
Turnover:27.15K
Market Cap:19.78M
PE:- -
High:37.67
Open:37.44
Low:37.44
Close:37.30
52wk High:38.66
52wk Low:31.32
Shares:525.00K
Float Shares:525.00K
Volume Ratio:0.75
T/O Rate:0.14%
Dividend:0.11
Dividend Rate:0.30%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

PainChek to Brief Investors on Global AI Pain Platform Expansion and U.S. Growth Strategy

TIPRANKS
·
2 hours ago

New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer

GlobeNewswire
·
5 hours ago

Estee Lauder Cos. Cl a Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
6 hours ago

Inventiva announces last patient visit in NATiV3 trial

TIPRANKS
·
6 hours ago

Johnson & Johnson to Present at Deutsche Bank 2026 Healthcare Summit

Reuters
·
6 hours ago

Option traders moderately bearish in Eli Lilly with shareslittle changed

TIPRANKS
·
9 hours ago

Sector Update: Healthcare

MT Newswires Live
·
9 hours ago

Johnson & Johnson's Drug Pipeline Supports Growth Outlook, UBS Securities Says

MT Newswires Live
·
Yesterday

LIVE Markets-Wall Street Starts Slow, Dow Leads

Reuters
·
Yesterday

Johnson & Johnson Stock (JNJ) Opened Up by 3.15% on Sep 2: Key Drivers Unveiled

TradingKey
·
Yesterday

Johnson & Johnson, Boeing Share Gains Contribute to Dow's 250-Point Climb

Dow Jones
·
Yesterday

Aspen Bets on Manufacturing Rebound, Obesity Drug Push for Growth

Reuters
·
Yesterday

Novartis Signs Deal Worth up to $3.2 Billion for Alteogen's Drug Delivery Technology

Reuters
·
Yesterday

Shenzhen Regulator Launches 2026 Roadshow Selection for Key Medical Device Innovation Projects

Deep News
·
Yesterday

Johnson & Johnson assumed with a Buy at UBS

TIPRANKS
·
Yesterday

Johnson & Johnson : UBS Raises Target Price to $320 from $280

THOMSON REUTERS
·
Yesterday

Merck CFO Litchfield, R&D Chief Li to Speak at Wells Fargo Healthcare Conference

Reuters
·
Yesterday

Guardant Health Price Target Maintained with a $195.00/Share by BTIG

Dow Jones
·
Yesterday

Shinva Medical Secures Class II and III Device Approvals for Advanced Radiotherapy and Thoracoscopic Systems

Stock News
·
Yesterday

港股动态:今海医疗科技股价攀升逾4%,中期收益激增逾1.3倍,核心业务向高附加值医疗器械领域转型

Stock News
·
Yesterday